[{"indications": "Indications\u00a0symptomatic relief of gastro-intestinal disorders characterised by\r\nsmooth muscle spasm", "name": "DICYCLOVERINE HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.2 Antispasmodics and other drugs altering gut motility", "Antimuscarinics"], "cautions": "Cautions\u00a0\n(From Antimuscarinics: British National Formulary)\nCautions\u00a0Antimuscarinics should be used with caution in Down\u2019s syndrome, in children and in the elderly; they should also be used with caution in gastro-oesophageal reflux disease, diarrhoea, ulcerative colitis, autonomic neuropathy, acute myocardial infarction, hypertension, conditions characterised by tachycardia (including hyperthyroidism, cardiac insufficiency, cardiac surgery), pyrexia, and in individuals susceptible to angle-closure glaucoma. Interactions: Appendix 1 (antimuscarinics).", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2059.htm", "doses": ["10\u201320\u00a0mg 3 times daily; infant 6\u201324 months 5\u201310\u00a0mg 3\u20134 times daily, 15 minutes before feeds; child 2\u201312 years 10\u00a0mg 3 times daily"], "pregnancy": "Pregnancy\u00a0not known to be harmful; manufacturer advises use\r\nonly if essential"}, {"indications": "Indications\u00a0symptomatic relief of gastro-intestinal disorders characterised by\r\nsmooth muscle spasm", "name": "DICYCLOVERINE HYDROCHLORIDE Compound preparations", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.2 Antispasmodics and other drugs altering gut motility", "Antimuscarinics", "DICYCLOVERINE HYDROCHLORIDE", "Compound preparations"], "cautions": "Cautions\u00a0\n(From Antimuscarinics: British National Formulary)\nCautions\u00a0Antimuscarinics should be used with caution in Down\u2019s syndrome, in children and in the elderly; they should also be used with caution in gastro-oesophageal reflux disease, diarrhoea, ulcerative colitis, autonomic neuropathy, acute myocardial infarction, hypertension, conditions characterised by tachycardia (including hyperthyroidism, cardiac insufficiency, cardiac surgery), pyrexia, and in individuals susceptible to angle-closure glaucoma. Interactions: Appendix 1 (antimuscarinics).", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2063.htm", "doses": ["10\u201320\u00a0mg 3 times daily; infant 6\u201324 months 5\u201310\u00a0mg 3\u20134 times daily, 15 minutes before feeds; child 2\u201312 years 10\u00a0mg 3 times daily", "Name[Kolanticon\u00ae (Peckforton)] Gel, sugar-free,\r\ndicycloverine hydrochloride 2.5\u00a0mg, dried aluminium hydroxide 200\u00a0mg, light magnesium oxide 100\u00a0mg, simeticone 20\u00a0mg/5\u00a0mL, net\r\nprice 200\u00a0mL = \u00a32.21, 500\u00a0mL = \u00a33.94Dose\u00a0adult and child over 12 years, 10\u201320\u00a0mL every 4 hours when\r\nrequired"], "pregnancy": "Pregnancy\u00a0not known to be harmful; manufacturer advises use\r\nonly if essential"}]